HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
ICOR 2016

Angel Arnaout

Angel Arnaout, Speaker at Cancer Conferences
University of Ottawa, Canada
Title : The Specimen Margin Assessment Technique (SMART) trial: A novel 3D method of identifying the most accurate method of breast specimen orientation

Abstract:

Every year, countless women will be diagnosed and treated for breast cancer, most of whom will require surgery. A clean margin around the cancer site is the only prognostic factor that a surgeon can control in order to reduce local recurrence. Having an accurate method of assessing margin status is imperative not only for better oncologic outcomes for the patient, but also to prevent unnecessary additional surgeries for re-excision, additional emotional distress for patients, delays in subsequent adjuvant therapy for breast cancer, and associated additional health care costs. There are two commonly used techniques that surgeons use to orient breast specimens for the pathologists: Intra-operative labelling of the margins with sutures and intra-operative inking of the margins. Using a creative, a novel 3D technique, we demonstrate the results of the world’s first prospective clinical trial that evaluates the accuracy of both techniques on the same lumpectomy specimen, in a blinded fashion, using with the aim of identifying the most accurate method of specimen orientation. The results of this trial are practice-changing with significant implications for patient safety and health care costs. This study will form the foundation for unifying breast cancer surgeons and pathologists on best practices for accurate specimen orientation and improved patient outcomes. Findings from the study can be extrapolated to the pathological assessment of other surgically resectable cancer types in which margin status is a quality indicator.

Biography:

Dr. Angel Arnaout is a Breast Surgical Oncologist at the Ottawa Hospital, Associate Professor at the University of Ottawa, Associate Scientist at the Ottawa Hospital Research Institute, and Medical Director of the Breast Health Center in Ottawa, Ontario, Canada. She is the creator innovative programs for breast cancer patients including the Ottawa Hospital Rapid Diagnosis and Support (RADS) Program, The Advanced Multidisciplinary (TEAM) Program of Ottawa, and the “Window of Opportunity” Clinical Trials Platform in Canada. Dr. Arnaout has won numerous national awards for her work including the “Best Innovation in Cancer Care Delivery Award” at the Canadian Ontario Provincial Showcase, the Canadian Association of General Surgeon’s Award, the Canadian Cancer Society Research Award, and the Canadian Breast Cancer Foundation Research Award. Dr. Arnaout has published over 40 scientific papers in peer-reviewed journals.

Watsapp